Stephen Glaser, MD
Disclosures: Nothing to disclose
cv

Stephen R. Glaser, M.D., FAAP, FACS

Board Certified,

Pediatric and Neonatal Ophthalmology

www.kidseyecare.com

301-580-8018

OFFICES:             

Montgomery County              Howard County              Frederick County

15235 Shady Grove Road               7625 Maple Lawn Blvd.              5283 Corporate Dr.

Suite 101              Suite 200              Suite 202

Rockville, MD 20850              Fulton, MD 20759               Frederick, MD 21703

 

Personal Information:

Place of Birth:                                            Washington, D.C.

Current Residence:                            Rockville, Maryland

 

CURRENT POSITION:

July 1997- present              President, KidsEyeCare of Maryland – Stephen R. Glaser, M.D. P.C. Montgomery Frederick and Howard Counties in Maryland.

 

March 1998- present                            Clinical Investigator (PI), Pediatric Eye Disease Investigator Group (PEDIG).

 

July 2018- present                            Clinical Investigator (PI), Luminopia (binocular amblyopia treatment)

 

September 2018- present              Founder and creator of “Pediatric Ophthalmologist” 300+ member private Facebook group.

                                                       

 

May 2008- present              Chief, Pediatric Ophthalmology Section, Holy Cross Hospital, Silver Spring, Maryland.

 

April 2014- present              Course Director and Moderator: ROPupdate.com (next meeting ROP Update 2018 in 12/2018 at Children’s Hospital of Philadelphia – CHOP).              

 

November 2003- present              Inventor and owner of US Patent #6,652,101: Method and Apparatus For Performing Vision Screening.                                         

                                                                     

Post-graduate training:

July 1996 - June 97                            Fellow in Pediatric Ophthalmology

                                                                                    Northwestern University/ Children’s Memorial Hospital

                                                                                    Chicago, Illinois

 

July 1993- June 96                            Resident in Ophthalmology

                                                                                    Georgetown University

                                                                                    Washington, D.C.

                                                       

June 1992-June 93                            Transitional Internship - Pediatrics and Medicine

                                                                      Georgetown University

                                                                      Washington, D.C.

 

Education:                            

August 1988- May 92                            M.D. 

                                                                      Case Western Reserve University School of Medicine                                                                                      Cleveland, Ohio 

                                         

May 1997                                                         B.A. with Honors in English                                                                                                                              The University of Michigan 

                                                                      Ann Arbor, Michigan 

 

RECENT HONORS AND AWARDS:

May, 2015              Inaugrial Pediatric Specialist Honoree Award: Montgomery County Pediatric Society for Top Area Pediatric Specialist.

Current Issue               Top Doc Award- Washingtonian Magazine, every issue since 2001.

Current Issue              Top Doctors- Washington Checkbook Magazine

Multiple awards since 1999              Early and high volume recruiting site: Pediatric Eye Disease Investigator Group (PEDIG) including #1 USA Prinicple Investigator site recruitment for NIH-PEDIG ATS-1 Enrollment.

HOSPITAL PRIVILEGES:

Holy Cross Hospital, Silver Spring, MD

Shady Grove Adventist Hospital, Rockville, MD

Howard County General Hospital, Columbia, MD

Washington Adventist Hospital, Takoma Park, MD

Frederick Memorial Hospital, Frederick, MD

Meritus Medical Center, Hagerstown, MD

Holy Cross Hospital, Germantown, MD

 

             

Professional Affiliations and Organizations:

Fellow, American Academy of Pediatrics (AAP)

              Elected Executive Comittee member, Section on Ophthalmology 2005-2007

Fellow, American Academy of Ophthalmology (AAO)

Fellow, American College of Surgeons (ACS)

Full member, American Association for Pediatric Ophthalmology and Strabismus (AAPOS)

 

Publications and Presentations:

Greenwald MJ, Glaser, SR.  Visual outcomes after surgery for unilateral cataract in children over two years old:  Intraocular lens implantation versus contact lens correction of aphakia.  J AAPOS. 1998 Jun;2(3):168-76.

 

Javitt JC, Wang F, McBean AM, Wang Q, Metrick S, Glaser, SR. The use and cost of physician services for ophthalmic surgical procedures in 1988 and 1991.  Ophthalmic Surgical Lasers 1996;27(7):575-582.

 

Rapheal B, Kerr NC, Shimizu RW, Lass JH, Crouthamel KC, Glaser SR, Stern GA, McLaughlin BJ, Musch DC, Duzman E.  Enhanced healing of cat corneal endothelial wounds by Epidermal Growth Factor.  Invest Ophthalmol Vis Sci. 34(7): 2305-12. 1993.             

             

Garcia-Ferrar FJ, Pepose JS, Murray PR, Glaser SR, Lass JH, Green WR.  Antimicrobial efficacy and corneal endothelial toxicity of Dexol corneal storage medium supplemented with vancomycin. Ophthalmology, 98:863-869. 1991.

 

Amato MM, Glaser SR, Mannor GE.  Medical versus surgical management of patients with orbital cellulitis.  Poster presented at 1996 ARVO meeting.

 

Glaser SR, Javitt JC, Garra BS.  Evaluation of optic nerve head blood flow (ONHBF) using Power Doppler.  Poster presented at 1996 ARVO meeting.

 

Smith JA, Hudak D, Glaser SR, Nussenblatt RB, Whitcup SM.  Prognostic factors for visual acuity               in sarcoid uveitis.  Poster presented at 1996 ARVO meeting.

 

Glaser SR and Rajpal RK.  Chapter 55, Antiseptics and Disinfectants in Zimmerman TJ. 

Textbook of Ocular Pharmacology.  Lippincott-Raven Press,  New York 1997.

 

Glaser SR, Javitt JC, Garra BS, Tillem J.  Quantification and implications of optic nerve head blood flow (ONHBF) using Power Doppler.  Presented at the thirty-third Annual Georgetown University Residents and Alumni Conference, Washington, D.C.  June, 1995.

 

Wagner DG, Glaser SR, Allen F, Ward T.  Localized retinal pigment epithelial lesions generated by               pulsed diode laser.  Presented at the 1995 Vitreous Society meeting, London, England.


Author and/or writing committee Pediatric Eye Investigator Group:

Protocol ATS1 - Amblyopia Treatment Study 1

1. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002;120(3):268-78 (Published). 
(Manuscript) | View Publication

  

2. Pediatric Eye Disease Investigator Group. The clinical profile of moderate amblyopia in children younger than 7 years.Arch Ophthalmol 2002;120(3):281-7 (Published). 
(Manuscript) | View Publication

  

3. Pediatric Eye Disease Investigator Group. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology 2003;110(8):1632-7; discussion 1637-8 (Published). 
(Manuscript) | View Publication

  

4. Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study. Am J Ophthalmol 2003;136(4):630-9 (Published). 
(Manuscript) | View Publication

  

5. Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with patching in children: experience of the amblyopia treatment study. Am J Ophthalmol 2003;136(4):620-9 (Published). 
(Manuscript) | View Publication

  

6. Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol 2003;121(11):1625-32 (Published). 
(Manuscript) | View Publication

  

7. Pediatric Eye Disease Investigator Group. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2005;123(2):149-57 (Published). 
(Manuscript) | View Publication

  

8. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol 2008;126(8):1039-44 (Published). 
(Manuscript) | View Publication

 

9. Pediatric Eye Disease Investigator Group. Contrast sensitivity following amblyopia treatment in children.  Arch Ophthalmol 2009;127(9):1225-7.

 

10. Pediatric Eye Disease Investigator Group. Effect of ocular alignment on emmetropization in children. Am J Ophthalmol 2012;154(2):297-302.

 

11. Pediatric Eye Disease Investigator Group. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trail.  JAMA Ophthalmol 2014;132(7):799-805

  

Protocol ATS2A - A Randomized Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia

Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003;110(11):2075-87 (Published). 
(Manuscript) | View Publication

  

 

Protocol ATS2B - A Randomized Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia

Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003;121(5):603-11 (Published). 
(Manuscript) | View Publication

  

Protocol ATS2C - Amblyopia Treatment Study 2C

Pediatric Eye Disease Investigator Group. Risk of amblyopia recurrence after cessation of treatment. J AAPOS 2004;8(5):420-8 (Published). 
(Manuscript) | View Publication

 

Protocol ATS4 – Amblyopia Treatment Study

Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology 2004;111(11):2076-85 (Published). 
(Manuscript) | View Publication

 

Protocol ATS05 - Amblyopia Treatment Study 5

1. Pediatric Eye Disease Investigator Group. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology 2006;113(6):904-12 (Published). 
(Manuscript) | View Publication

  

2. Pediatric Eye Disease Investigator Group. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology 2006;113(6):895-903 (Published). 
(Manuscript) | View Publication

  

3. Pediatric Eye Disease Investigator Group. Treatment of strabismic amblyopia with refractive correction. Am J Ophthalmol 2007;143(6):1060-3 (Published). 
(Manuscript) | View Publication

  

Protocol ATS06 - Amblyopia Treatment Study 6

 

Pediatric Eye Disease Investigator Group. A randomized trial of near versus distance activities while patching for amblyopia in children aged 3 to less than 7 years. Ophthalmology 2008;115(11):2071-8 (Published). 
(Manuscript) | View Publication

Protocol ATS08 - Amblyopia Treatment Study 8

Pediatric Eye Disease Investigator Group. Pharmacologic plus optical penalization treatment for amblyopia: results of a randomized trial. Arch Ophthalmol 2009;127(1):22-30 (Published). 
(Manuscript) | View Publication

  

Protocol ATS09 - Amblyopia Treatment Study 9

Pediatric Eye Disease Investigator Group. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol 2008;126(12):1634-42 (Published). 
(Manuscript) | View Publication

Protocol ATS13 - Spectacles for Strabismic Amblyopia

Pediatric Eye Disease Investigator Group. Optical Treatment of Strabismic and Combined Strabismic-Anisometropic Amblyopia. Ophthalmology 2012;119(1):150-8. (Published). 
(Manuscript) | View Publication

  

Protocol ATS14 - Levodopa for Amblyopia Pilot

Repka MX, Kraker RT, Beck RW, et al. Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years. Arch Ophthalmol. 2010 Sep;128(9):1215-7. (Published). 
(Manuscript) | View Publication

 

Protocol ATS15 – Increasing Patching for Amblyopia Study

Pediatric Eye Disease Investigator Group. A randomized trial of increasing patching for amblyopia. Ophthalmology. 2013 Nov;120(11):2270-7. Epub 2013 Jun 4 (Published). 
(Manuscript) | View Publication

 

Pediatric Eye Disease Investigator Group.  Time course and predictors of amblyopia improvement with 2 hours of daily patching. JAMA Ophthalmol 2015;133:606-9.

 

Protocol A10 - Bangerter Filter Treatment Study

Pediatric Eye Disease Investigator Group. A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children. Ophthalmology. 2010 May;117(5):998-1004.e6. Epub 2010 Feb 16. (Published). 
(Manuscript) | View Publication

 

Pediatric Eye Disease Investigator Group. A Visual acuity through Bangerter filters in non-amblyopic eyes.  J AAPOS 2011;15(2):131-4

 

Protocol A11 - Residual Amblyopia Treatment Study

Pediatric Eye Disease Investigator Group. A Randomized Trial to Evaluate Combined Patching and Atropine for Residual Amblyopia. Arch Ophthalmol 2011;129(7):960-2 (Published). 
(Manuscript) | View Publication

 

Protocol CCTS - Central Corneal Thickness Study

Pediatric Eye Disease Investigator Group. Central Corneal Thickness in Children. Arch Ophthalmol. 2011;129(9):1132-8. (Published). 
(Manuscript) | View Publication

Protocol ETS01 - Esotropia Treatment Study 1

1. Pediatric Eye Disease Investigator Group. Instability of ocular alignment in childhood esotropia. Ophthalmology 2008;115(12):2266–74 (Published). 
(Manuscript) | View Publication

  

2. Pediatric Eye Disease Investigator Group. Interobserver reliability of the Prism and Alternate Cover Test in children with esotropia. Arch Ophthalmol 2009;127(1):59-65 (Published). 
(Manuscript) | View Publication

  

3. Pediatric Eye Disease Investigator Group. The relationship between preoperative alignment stability and postoperative motor outcomes in children with esotropia. J AAPOS 2009;13(4):335-8 (Published). 
(Manuscript) | View Publication

 

4. Pediatric Eye Disease Investigator Group. Classifying stability of misalignment in children with esotropia using simulations. Arch Ophthalmol 2010;128(12):1555-60 

 

Protocol NLD01 - Nasolacrimal Duct Obstruction 1

1. Pediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology 2008;115(3):577-84 (Published). 
(Manuscript) | View Publication

  

2. Pediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age. J AAPOS 2008;12(5):451-5 (Published). 
(Manuscript) | View Publication

  

3. Pediatric Eye Disease Investigator Group. Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age. J AAPOS 2008;12(5):445-50 (Published). 
(Manuscript) | View Publication

 

 

Protocol CEOS1- Congential Esotropia Observational Study

 

1. Pediatric Eye Disease Investigator Group. The natural history of infantile esotropia during the first six month of life.  J AAPOS 1998;2(6):325-8

 

2. Pediatric Eye Disease Investigator Group. The clinical spectrum of early-onset esotropia: experience of the Congenital Esotropia Observational Study . Am J Ophthalmol 2002;133(1):102-8.

3. Pediatric Eye Disease Investigator Group. Spontanious resolution of early-onset esotropia experience of the Congenital Esotropia Observational Study. Am J Ophthalmol 2002;133(1):109-18.

Protocol IXT-2 Intermittent Exotropia Study.

Pediatric Eye Disease Investigator Group. A randomized trial comparing part-time patching with observation for children 3-10 years old with intermittent exotropia. Ophthalmology 2014;121:2299-310.

Protocol A16 - Augmenting Atropine Treatment for Amblyopia

Pediatric Eye Disease Investigator Group. A randomized trial of adding a plano lens to atropine for amblyopia.  J AAPOS 2015;19:42-8. 

Protocol A17 - Levodopa for Residual Amblyopia Study

Pediatric Eye Disease Investigator Group. A randomized trial of levodopa as treatment for residual amblyopia in older children. Ophthalmology 2015;122:874-81.